Advertisement

Topics

Sawai Pharmaceutical To Sell 20 Percent Stake In U.S. Subsidiary To Sumitomo Corp.

07:05 EST 14 Nov 2017 | Pharmaceutical Processing

Under the terms of the agreement, Sumitomo Corporation of Americas will acquire the stake for consideration of $211 million. The transaction is expected to close by the end of March 2018.
Contributed Author: 
Upsher-Smith Laboratories, LLC
Topics: 

Original Article: Sawai Pharmaceutical To Sell 20 Percent Stake In U.S. Subsidiary To Sumitomo Corp.

NEXT ARTICLE

More From BioPortfolio on "Sawai Pharmaceutical To Sell 20 Percent Stake In U.S. Subsidiary To Sumitomo Corp."

Advertisement
Quick Search
Advertisement
Advertisement